Novel GDF2 Gene Mutation Associated with Pulmonary Arteriovenous Malformation

J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105301. doi: 10.1016/j.jstrokecerebrovasdis.2020.105301. Epub 2020 Sep 15.

Abstract

Pulmonary arteriovenous malformations (PAVMs) are pathologic low-resistance conduits between a pulmonary artery and vein. Over 80% PAVMs occur in patients with hereditary hemorrhagic telangiectasia (HHT) and result from mutations in the transforming growth factor-beta signaling pathway. Mutations in the Growth Differentiation Factor 2 (GDF2) gene have recently been described to result in a vascular-anomaly syndrome with phenotypic overlap with HHT. We report a 43-year-old woman with a PAVM related ischemic stroke who was subsequently found to have a novel GDF2 gene mutation. The patient underwent coil-embolization of the PAVM with stable clinical and radiographic follow-up. It is important to diagnose PAVMs as they are an important cause of stroke-in-young; and can be treated definitively, reducing risk of recurrent stroke and migraine.

Keywords: GDF2; HHT; PAVM; Stroke.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Arteriovenous Malformations / complications
  • Arteriovenous Malformations / diagnostic imaging
  • Arteriovenous Malformations / genetics*
  • Arteriovenous Malformations / therapy
  • Brain Ischemia / etiology
  • Embolization, Therapeutic
  • Female
  • Genetic Predisposition to Disease
  • Growth Differentiation Factor 2 / genetics*
  • Humans
  • Mutation, Missense*
  • Phenotype
  • Pulmonary Artery / abnormalities*
  • Pulmonary Artery / diagnostic imaging
  • Pulmonary Veins / abnormalities*
  • Pulmonary Veins / diagnostic imaging
  • Stroke / etiology
  • Treatment Outcome

Substances

  • GDF2 protein, human
  • Growth Differentiation Factor 2